Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan

被引：0
|
作者：
Suzuki, Sho [1 ,2 ]
Ishibashi, Fumiaki [1 ,2 ]
Gotoda, Takuji [3 ]
机构：
[1] Int Univ Hlth, Dept Gastroenterol, Ichikawa, Japan
[2] Welf Ichikawa Hosp, Ichikawa, Japan
[3] Nihon Univ, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan
来源：
INTERNAL MEDICINE | 2023年 / 62卷 / 16期
关键词：
Helicobacter pylori; clarithromycin resistance; penicillin allergy; vonoprazan; THERAPY;
D O I：
10.2169/internalmedicine.1282-22
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2299 / 2300
页数：2
相关论文
共 50 条
  • [1] Comparison of metronidazole versus clarithromycin in first-line vonoprazan-based triple therapy for Helicobacter pylori: A multicenter randomized trial in Japan
    Sue, Soichiro
    Oka, Hiroyuki
    Kunishi, Yosuke
    Suzuki, Yuichi
    Suzuki, Shingo
    Kaneko, Takashi
    Komatsu, Kazuo
    Naito, Makoto
    Kato, Yoshio
    Sasaki, Tomohiko
    Kaneko, Hiroaki
    Irie, Kuniyasu
    Kondo, Masaaki
    Maeda, Shin
    JGH OPEN, 2024, 8 (04):
  • [2] Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection
    Yu, Jing
    Lv, Yi-Ming
    Yang, Peng
    Jiang, Yi-Zhou
    Qin, Xiang-Rong
    Wang, Xiao-Yong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (20) : 3133 - 3144
  • [3] Efficacy of Helicobacter pylori eradication with vonoprazan-based triple therapy
    Noda, Hiroto
    Goto, Osamu
    Koizumi, Eriko
    Agawa, Shuhei
    Ikeda, Go
    Higuchi, Kazutoshi
    Akimoto, Teppei
    Yamawaki, Hiroshi
    Kodaka, Yasuhiro
    Ueki, Nobue
    Futagami, Seiji
    Fujimori, Shunji
    Kaise, Mitsuru
    Iwakiri, Katsuhiko
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 364 - 364
  • [4] Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori
    Sue, Soichiro
    Suzuki, Yuichi
    Sasaki, Tomohiko
    Kaneko, Hiroaki
    Irie, Kuniyasu
    Komatsu, Kazuto
    Maeda, Shin
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)
  • [5] Comparison of vonoprazan-based dual therapy with vonoprazan-based bismuth quadruple therapy for treatment-naive patients with Helicobacter pylori infection: A propensity score matching analysis
    Liu, Zhu
    Chen, Xin
    Sun, Dong-Jie
    Zhao, Wen-Wen
    Kou, Luan
    Zheng, Wen-Wen
    Hao, Jiao-Rong
    Gao, Feng-Yu
    MEDICINE, 2024, 103 (10) : E37476
  • [6] Vonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidence
    Akazawa, Yuko
    Fukuda, Daisuke
    Fukuda, Yutaka
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (06) : 845 - 852
  • [7] Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy
    Sue, Soichiro
    Sasaki, Tomohiko
    Kaneko, Hiroaki
    Irie, Kuniyasu
    Kondo, Masaaki
    Maeda, Shin
    JGH OPEN, 2021, 5 (02): : 307 - 311
  • [8] Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?
    Abadi, Amin Talebi Bezmin
    Ierardi, Enzo
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [9] Effect of Concomitant Use of Polaprezinc and Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication
    Suzuki, Yuto
    Katayama, Yasumi
    Fujimoto, Yo
    Toyoda, Koji
    Takahashi, Morio
    Tamano, Masaya
    GASTROENTEROLOGY INSIGHTS, 2024, 15 (02) : 386 - 395
  • [10] Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility
    Hidetaka Okubo
    Junichi Akiyama
    Masao Kobayakawa
    Megumi Kawazoe
    Saori Mishima
    Yusuke Takasaki
    Naoyoshi Nagata
    Takayuki Shimada
    Chizu Yokoi
    Shiori Komori
    Kana Kimura
    Yuya Hisada
    Eri Iwata
    Kazuhiro Watanabe
    Naohiro Yanagisawa
    Sho Shiroma
    Akira Shimomura
    Koki Okahara
    Hourin Cho
    Naomi Uemura
    Journal of Gastroenterology, 2020, 55 : 1054 - 1061
12345